Synopsys (SNPS) Financials

$516.19 -0.29 (-0.06%)

Closing price 04:00 PM Eastern

Extended Trading

$514.38 -1.81 (-0.35%)

As of 04:35 PM Eastern

Annual Income Statements for Synopsys

This table shows Synopsys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Net Income / (Loss) Attributable to Common Shareholders	226	267	137	433	532	664	758	985	1,230	2,263	1,332
Consolidated Net Income / (Loss)	226	267	137	433	532	663	756	978	1,218	2,236	1,333
Net Income / (Loss) Continuing Operations	226	267	137	433	532	663	756	964	1,215	1,414	1,337
Total Pre-Tax Income	282	330	383	364	546	638	806	1,103	1,305	1,514	1,393
Total Operating Income	266	317	348	360	520	620	735	1,149	1,273	1,356	915
Total Gross Profit	1,723	1,880	2,071	2,385	2,608	2,891	3,342	3,718	4,287	4,882	5,431
Total Revenue	2,242	2,423	2,725	3,121	3,361	3,685	4,204	4,616	5,318	6,127	7,054
Operating Revenue	2,242	2,423	2,725	3,121	3,361	3,685	4,204	4,616	5,318	6,127	7,054
Total Cost of Revenue	519	543	654	736	753	795	862	898	1,031	1,245	1,624
Operating Cost of Revenue	519	543	654	736	753	795	862	898	1,031	1,245	1,624
Total Operating Expenses	1,457	1,562	1,723	2,025	2,088	2,270	2,608	2,569	3,014	3,526	4,516
Selling, General & Admin Expense	165	166	197	263	229	285	323	314	377	568	770
Marketing Expense	474	502	549	623	633	632	712	643	725	859	1,074
Research & Development Expense	776	857	909	1,085	1,137	1,279	1,505	1,590	1,850	2,082	2,479
Amortization Expense	-	-	-	42	-	-	-	12	9.30	16	193
Restructuring Charge	15	9.63	37	13	47	36	33	11	53	0.00	0.00
Total Other Income / (Expense), net	15	12	36	3.32	25	18	71	-45	32	158	478
Interest Expense	-	-	-	-	-	-	-	-	2.70	37	447
Other Income / (Expense), net	15	12	36	3.32	25	18	71	-45	35	195	925
Income Tax Expense	56	63	247	-69	13	-25	49	139	90	100	56
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-	14	2.84	822	-3.90
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	0.00	0.00	-0.90	-1.16	-6.16	-12	-28	1.03
Basic Earnings per Share	$1.46	$1.76	$0.91	$2.90	$3.55	$4.40	$4.96	$6.44	$8.08	$14.78	$8.13
Weighted Average Basic Shares Outstanding	154.96M	152.02M	150.46M	149.04M	149.87M	151.14M	152.70M	153.00M	152.15M	153.14M	163.95M
Diluted Earnings per Share	$1.43	$1.73	$0.88	$2.82	$3.45	$4.27	$4.81	$6.29	$7.92	$14.51	$8.04
Weighted Average Diluted Shares Outstanding	158.07M	154.72M	154.87M	153.39M	154.19M	155.71M	157.34M	156.49M	155.20M	155.94M	165.66M
Weighted Average Basic & Diluted Shares Outstanding	154.70M	151.60M	148.71M	149.52M	150.53M	153.03M	153.44M	152.42M	151.99M	154.58M	191.32M

This table shows Synopsys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026
Net Income / (Loss) Attributable to Common Shareholders	336	349	449	292	408	1,114	296	345	243	449	65
Consolidated Net Income / (Loss)	333	346	446	289	405	1,096	297	345	242	448	65
Net Income / (Loss) Continuing Operations	668	5.80	435	296	423	249	297	349	242	448	65
Total Pre-Tax Income	326	404	457	342	392	315	291	396	189	517	79
Total Operating Income	300	425	353	332	360	304	252	376	165	121	203
Total Gross Profit	1,094	1,102	1,232	1,154	1,235	1,173	1,185	1,286	1,359	1,600	1,771
Total Revenue	1,354	1,340	1,511	1,455	1,526	1,498	1,455	1,604	1,740	2,255	2,409
Operating Revenue	1,354	1,340	1,511	1,455	1,526	1,498	1,455	1,604	1,740	2,255	2,409
Total Cost of Revenue	260	238	279	300	291	325	270	318	381	655	637
Operating Cost of Revenue	260	238	279	300	291	325	270	318	381	655	637
Total Operating Expenses	794	677	879	822	875	869	934	909	1,194	1,479	1,568
Selling, General & Admin Expense	100	95	131	115	150	165	167	136	281	186	183
Marketing Expense	186	148	219	210	211	175	209	215	259	390	396
Research & Development Expense	484	440	526	493	509	528	553	554	625	747	715
Amortization Expense	2.01	-	3.53	4.56	4.06	-	4.00	4.00	29	156	156
Restructuring Charge	22	-4.07	-	-	-	-	0.00	-	-	-	118
Total Other Income / (Expense), net	25	-21	105	9.46	32	11	39	20	24	395	-124
Interest Expense	-	-	-	7.07	12	-	11	94	147	-	163
Other Income / (Expense), net	25	-21	105	17	44	11	50	114	171	601	39
Income Tax Expense	-6.95	63	23	45	-31	66	-6.29	47	-53	68	14
Net Income / (Loss) Attributable to Noncontrolling Interest	-3.20	-2.70	-2.91	-3.02	-3.16	-18	1.73	-0.22	-0.23	-0.24	-0.24
Basic Earnings per Share	$2.21	$2.30	$2.95	$1.91	$2.66	$7.26	$1.91	$2.23	$1.51	$2.48	$0.34
Weighted Average Basic Shares Outstanding	152.02M	152.15M	152.31M	152.97M	153.42M	153.14M	154.41M	154.93M	160.17M	163.95M	189.59M
Diluted Earnings per Share	$2.17	$2.24	$2.89	$1.88	$2.61	$7.13	$1.89	$2.21	$1.50	$2.44	$0.34
Weighted Average Diluted Shares Outstanding	154.95M	155.20M	155.33M	155.77M	156.13M	155.94M	156.19M	156.09M	161.68M	165.66M	190.76M
Weighted Average Basic & Diluted Shares Outstanding	304.17M	151.99M	152.54M	153.22M	153.61M	154.58M	154.62M	155.16M	185.75M	191.32M	191.56M

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Net Change in Cash & Equivalents	-150	140	70	-325	2.74	507	197	-15	21	2,458	-1,005
Net Cash From Operating Activities	495	587	632	424	801	991	1,493	1,739	1,703	1,407	1,519
Net Cash From Continuing Operating Activities	495	587	632	424	801	991	1,493	1,739	1,703	1,407	1,519
Net Income / (Loss) Continuing Operations	226	267	137	433	532	663	756	978	1,218	2,236	1,333
Consolidated Net Income / (Loss)	226	267	137	433	532	663	756	978	1,218	2,236	1,333
Depreciation Expense	212	207	189	209	202	210	204	228	247	295	660
Amortization Expense	-	-	0.00	0.00	63	61	65	73	82	107	109
Non-Cash Adjustments To Reconcile Net Income	88	99	112	142	162	357	466	555	694	-116	505
Changes in Operating Assets and Liabilities, net	-30	14	195	-360	-158	-300	1.60	-96	-538	-1,115	-1,089
Net Cash From Investing Activities	-560	-143	-189	-744	-236	-360	-549	-573	-482	1,223	-15,881
Net Cash From Continuing Investing Activities	-560	-143	-189	-744	-236	-360	-549	-573	-482	1,223	-15,881
Purchase of Property, Plant & Equipment	-91	-71	-74	-102	-202	-159	-96	-139	-192	-140	-169
Acquisitions	-340	-60	-259	-653	-37	-201	-296	-422	-298	-157	-16,681
Purchase of Investments	-239	-170	-155	-3.56	-3.25	-2.76	-169	-104	-132	-138	-70
Sale of Property, Plant & Equipment	-	0.00	0.00	1.66	-	-	-	-	0.00	16	74
Divestitures	-	-	-	-	-	-	-	0.00	0.00	1,447	747
Sale and/or Maturity of Investments	109	158	296	13	6.36	2.15	13	94	139	195	219
Other Investing Activities, net	0.90	0.00	2.10	-	0.00	0.00	-0.80	-1.20	0.00	0.00	-0.37
Net Cash From Financing Activities	-62	-307	-373	5.14	-562	-141	-749	-1,116	-1,197	-181	13,356
Net Cash From Continuing Financing Activities	-62	-307	-373	5.14	-562	-141	-749	-1,116	-1,197	-181	13,356
Repayment of Debt	-327	-191	-383	-294	-525	-290	-32	-80	-2.73	-76	-867
Repurchase of Common Equity	-280	-400	-400	-400	-329	-242	-788	-1,100	-1,206	0.00	0.00
Payment of Dividends	-	-	-	-	-	-	-	-	0.00	0.00	-30
Issuance of Debt	460	185	320	621	193	276	-	-	0.00	0.00	14,329
Issuance of Common Equity	110	125	126	124	156	197	211	238	253	232	228
Other Financing Activities, net	-25	-27	-37	-46	-57	-82	-139	-174	-241	-338	-306
Effect of Exchange Rate Changes	-23	3.41	-	-11	-	17	2.37	-65	-2.98	8.80	1.90
Cash Interest Paid	2.71	3.71	7.10	15	12	5.14	3.37	1.26	1.00	0.81	354
Cash Income Taxes Paid	60	69	103	253	76	71	150	168	98	680	513

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026
Net Change in Cash & Equivalents	142	-247	-320	390	348	2,039	-241	10,466	-11,591	362	-759
Net Cash From Operating Activities	560	326	-88	477	455	563	-67	275	671	640	857
Net Cash From Continuing Operating Activities	560	326	-88	477	455	563	-67	275	671	640	857
Net Income / (Loss) Continuing Operations	333	346	446	289	405	1,096	297	345	242	448	65
Consolidated Net Income / (Loss)	333	346	446	289	405	1,096	297	345	242	448	65
Depreciation Expense	63	67	63	61	56	115	48	49	114	449	451
Amortization Expense	22	21	20	25	31	32	23	45	20	21	32
Non-Cash Adjustments To Reconcile Net Income	179	179	155	204	209	-684	222	71	-22	233	303
Changes in Operating Assets and Liabilities, net	-37	-287	-772	-103	-245	4.52	-658	-235	316	-512	6.44
Net Cash From Investing Activities	-54	-301	-54	-112	-54	1,443	-22	76	-16,500	564	-37
Net Cash From Continuing Investing Activities	-54	-301	-54	-112	-54	1,443	-22	76	-16,500	564	-37
Purchase of Property, Plant & Equipment	-46	-53	-40	-38	-40	-4.39	-41	-56	-39	-35	-35
Purchase of Investments	-34	-29	-26	-40	-32	-40	-41	-10	-0.72	-18	-4.90
Divestitures	-	-	0.00	-	-	-	24	46	72	604	0.00
Sale and/or Maturity of Investments	36	28	80	39	35	40	36	21	148	13	3.72
Other Investing Activities, net	-	-	0.00	-	-	-	-0.61	-	-	0.25	0.00
Net Cash From Financing Activities	-351	-254	-187	33	-57	30	-142	10,096	4,237	-836	-1,583
Net Cash From Continuing Financing Activities	-351	-254	-187	33	-57	30	-142	10,096	4,237	-836	-1,583
Repayment of Debt	-1.31	-	-49	-7.81	-19	-	-1.29	-	-1.75	-863	-3,451
Payment of Dividends	-	-	0.00	-	-	-	-30	-	-	-	0.00
Issuance of Common Equity	32	88	9.48	106	28	89	14	104	20	90	2,013
Other Financing Activities, net	-82	-42	-147	-65	-66	-59	-125	-42	-76	-63	-145
Effect of Exchange Rate Changes	-13	-18	9.32	-6.90	3.04	3.34	-9.68	18	0.46	-6.75	3.43

This table presents Synopsys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Total Assets	5,046	5,240	5,396	6,146	6,405	8,030	8,752	9,418	10,333	13,074	48,224
Total Current Assets	1,469	1,717	1,683	1,544	1,739	2,549	2,808	3,013	3,431	6,470	6,012
Cash & Equivalents	836	977	1,048	723	729	1,236	1,433	1,418	1,434	3,897	2,888
Short-Term Investments	129	141	-	-	-	0.00	148	148	152	154	73
Accounts Receivable	386	439	451	554	554	781	569	796	857	934	1,505
Inventories, net	-	-	62	122	142	192	229	212	326	362	365
Prepaid Expenses	71	105	73	68	290	308	430	439	548	1,123	1,181
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	115	-	0.00
Plant, Property, & Equipment, net	263	257	266	309	430	484	472	483	550	563	697
Total Noncurrent Assets	3,314	3,266	3,448	4,293	4,237	4,997	5,472	5,922	6,353	6,041	41,516
Goodwill	2,471	2,518	2,707	3,143	3,171	3,365	3,576	3,842	3,346	3,449	26,899
Intangible Assets	364	267	254	360	279	254	279	386	240	195	12,680
Noncurrent Deferred & Refundable Income Taxes	274	282	244	404	390	498	613	671	854	1,247	112
Other Noncurrent Operating Assets	205	200	243	385	396	880	1,004	1,023	1,005	1,150	1,825
Total Liabilities & Shareholders' Equity	5,046	5,240	5,396	6,146	6,405	8,030	8,752	9,418	10,333	13,074	48,224
Total Liabilities	1,912	2,045	2,117	2,661	2,316	3,118	3,453	3,859	4,149	4,050	19,897
Total Current Liabilities	1,578	1,715	1,614	2,102	1,752	2,140	2,413	2,774	2,985	2,650	3,722
Short-Term Debt	205	205	9.92	344	18	27	75	-	-	0.00	22
Accounts Payable	386	401	500	578	506	624	741	809	1,060	1,164	1,326
Current Deferred Revenue	968	1,086	1,065	1,153	1,212	1,388	1,518	1,911	1,559	1,392	2,246
Other Current Liabilities	-	-	-	-	0.00	73	80	54	80	95	128
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	286	-	0.00
Total Noncurrent Liabilities	333	330	503	559	564	978	1,040	1,084	1,163	1,400	16,175
Long-Term Debt	-	0.00	134	126	120	101	25	21	18	16	13,462
Noncurrent Deferred Revenue	131	119	116	167	120	130	136	154	151	341	383
Other Noncurrent Operating Liabilities	202	211	252	266	324	747	878	909	961	1,044	2,330
Total Equity & Noncontrolling Interests	3,134	3,195	3,280	3,485	4,089	4,912	5,299	5,521	6,153	8,993	28,327
Total Preferred & Common Equity	3,134	3,195	3,276	3,479	4,083	4,907	5,295	5,516	6,147	8,991	28,328
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,134	3,195	3,276	3,479	4,083	4,907	5,295	5,516	6,147	8,991	28,328
Common Stock	1,612	1,646	1,624	1,646	1,637	1,655	1,578	1,489	1,278	1,213	18,643
Retained Earnings	1,726	1,948	2,144	2,544	3,164	3,795	4,550	5,534	6,742	8,984	10,315
Treasury Stock	-98	-294	-426	-598	-626	-489	-783	-1,273	-1,676	-1,026	-398
Accumulated Other Comprehensive Income / (Loss)	-105	-105	-66	-113	-92	-54	-50	-234	-196	-180	-232
Noncontrolling Interest	-	0.00	4.10	5.86	5.86	4.96	3.81	4.80	5.95	2.50	-0.59

This table presents Synopsys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	4/30/2023	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	1/31/2026
Total Assets	9,791	9,923	10,333	10,558	11,012	11,649	13,074	13,041	23,757	48,230	47,238
Total Current Assets	3,161	3,268	3,431	3,408	4,653	5,128	6,470	6,324	16,879	5,596	5,374
Cash & Equivalents	1,545	1,686	1,434	1,119	1,503	1,840	3,897	3,654	14,119	2,526	2,130
Short-Term Investments	151	148	152	154	157	154	154	155	145	67	74
Accounts Receivable	780	667	857	1,064	835	805	934	893	1,002	1,392	1,641
Inventories, net	256	283	326	383	378	386	362	415	395	382	393
Prepaid Expenses	429	484	548	688	760	915	1,123	1,206	1,218	1,153	1,088
Other Current Nonoperating Assets	-	-	115	-	1,020	1,028	-	-	-	74	48
Plant, Property, & Equipment, net	546	536	550	567	567	571	563	546	572	700	677
Total Noncurrent Assets	6,083	6,119	6,353	6,583	5,792	5,950	6,041	6,171	6,306	41,935	41,188
Goodwill	3,888	3,888	3,346	4,131	3,427	3,444	3,449	3,433	3,461	26,946	26,881
Intangible Assets	357	337	240	377	277	266	195	181	173	13,080	12,290
Noncurrent Deferred & Refundable Income Taxes	774	814	854	954	1,005	1,103	1,247	1,393	1,509	97	117
Other Noncurrent Operating Assets	1,064	1,081	1,005	1,120	1,083	1,136	1,150	1,164	1,162	1,812	1,900
Total Liabilities & Shareholders' Equity	9,791	9,923	10,333	10,558	11,012	11,649	13,074	13,041	23,757	48,230	47,238
Total Liabilities	3,918	3,923	4,149	3,852	3,823	3,903	4,050	3,736	13,841	20,616	16,690
Total Current Liabilities	2,749	2,730	2,985	2,645	2,508	2,535	2,650	2,359	2,406	3,444	3,943
Short-Term Debt	-	-	-	-	-	-	-	-	23	22	22
Accounts Payable	702	905	1,060	699	636	757	1,164	939	904	1,283	1,305
Current Deferred Revenue	1,969	1,744	1,559	1,856	1,457	1,357	1,392	1,321	1,375	1,991	2,459
Other Current Liabilities	78	80	80	89	85	90	95	99	104	127	133
Other Current Nonoperating Liabilities	-	-	286	-	331	331	-	-	-	20	24
Total Noncurrent Liabilities	1,169	1,193	1,163	1,207	1,315	1,368	1,400	1,378	11,435	17,172	12,747
Long-Term Debt	20	18	18	17	17	16	16	14	10,028	14,318	10,022
Noncurrent Deferred Revenue	191	195	151	190	308	319	341	316	331	383	421
Other Noncurrent Operating Liabilities	958	980	961	1,000	990	1,034	1,044	1,047	489	2,470	2,304
Total Equity & Noncontrolling Interests	5,837	5,964	6,153	6,676	7,158	7,714	8,993	9,305	9,916	27,614	30,548
Total Preferred & Common Equity	5,832	5,959	6,147	6,671	7,153	7,709	8,991	9,305	9,916	27,615	30,549
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,832	5,959	6,147	6,671	7,153	7,709	8,991	9,305	9,916	27,615	30,549
Common Stock	1,332	1,259	1,278	1,185	1,184	1,194	1,213	1,129	1,221	18,552	20,564
Retained Earnings	6,075	6,390	6,742	7,189	7,478	7,884	8,984	9,279	9,624	9,867	10,380
Treasury Stock	-1,429	-1,543	-1,676	-1,539	-1,322	-1,188	-1,026	-861	-689	-572	-192
Accumulated Other Comprehensive Income / (Loss)	-146	-147	-196	-163	-188	-180	-180	-242	-240	-232	-204
Noncontrolling Interest	5.09	5.45	5.95	4.59	4.64	4.98	2.50	0.11	-0.11	-0.35	-0.83

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	10/31/2015	10/31/2016	10/31/2017	10/31/2018	10/31/2019	10/31/2020	10/31/2021	10/31/2022	10/31/2023	10/31/2024	10/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.98%	8.04%	12.48%	14.54%	7.68%	9.66%	14.08%	9.79%	15.22%	15.22%	15.12%
EBITDA Growth	6.12%	8.74%	6.70%	0.04%	41.41%	12.27%	18.10%	30.82%	16.36%	17.21%	33.61%
EBIT Growth	3.48%	17.02%	16.25%	-5.10%	50.05%	16.98%	26.22%	36.99%	18.31%	15.96%	18.65%
NOPAT Growth	-9.73%	20.21%	-51.79%	245.91%	18.46%	26.99%	7.02%	45.46%	18.10%	6.85%	-30.66%
Net Income Growth	-12.81%	18.10%	-48.82%	216.72%	23.09%	24.62%	14.00%	29.36%	24.50%	83.55%	-40.37%
EPS Growth	-12.80%	20.98%	-49.13%	220.45%	22.34%	23.77%	12.65%	30.77%	25.91%	83.21%	-44.59%
Operating Cash Flow Growth	-10.13%	18.47%	7.82%	-32.90%	88.62%	23.83%	50.57%	16.50%	-2.05%	-17.39%	7.93%
Free Cash Flow Firm Growth	60.63%	2,442.96%	-90.99%	-1,461.98%	156.38%	40.33%	100.05%	19.37%	59.40%	-85.17%	-17,381.22%
Invested Capital Growth	10.66%	-3.84%	4.05%	36.03%	8.26%	8.77%	0.36%	5.14%	-2.53%	27.49%	678.82%
Revenue Q/Q Growth	2.19%	1.96%	2.36%	3.26%	1.69%	4.97%	3.11%	-6.75%	1.05%	-5.64%	9.62%
EBITDA Q/Q Growth	-0.20%	3.62%	2.38%	-5.61%	11.95%	7.20%	0.99%	0.58%	14.12%	-1.34%	39.75%
EBIT Q/Q Growth	-2.16%	8.86%	4.69%	-11.59%	17.03%	10.37%	0.94%	0.09%	17.24%	-5.33%	29.43%
NOPAT Q/Q Growth	-3.21%	9.16%	-59.35%	676.85%	-16.37%	7.27%	-1.12%	-5.17%	20.78%	-8.90%	-17.02%
Net Income Q/Q Growth	-5.32%	9.40%	-58.53%	644.33%	-14.95%	5.71%	0.61%	-4.82%	19.05%	50.39%	-32.68%
EPS Q/Q Growth	-4.67%	9.49%	-58.49%	605.00%	-15.44%	6.22%	0.00%	-4.41%	18.92%	50.83%	-36.84%
Operating Cash Flow Q/Q Growth	-3.97%	-0.80%	5.88%	-10.89%	12.72%	-1.89%	12.72%	1.34%	-3.81%	20.23%	5.34%
Free Cash Flow Firm Q/Q Growth	-108.82%	124.86%	-44.60%	1.24%	-6.09%	7.98%	4.33%	24.58%	36.85%	-62.08%	0.58%
Invested Capital Q/Q Growth	6.56%	-1.11%	-7.09%	6.14%	3.04%	3.31%	2.31%	-3.09%	-6.47%	-1.62%	-1.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	76.86%	77.59%	75.99%	76.42%	77.60%	78.44%	79.50%	80.54%	80.62%	79.68%	76.98%
EBITDA Margin	22.01%	22.15%	21.01%	18.35%	24.10%	24.67%	25.54%	30.44%	30.74%	31.27%	36.99%
Operating Margin	11.88%	13.10%	12.76%	11.54%	15.48%	16.83%	17.48%	24.89%	23.94%	22.13%	12.97%
EBIT Margin	12.56%	13.60%	14.06%	11.65%	16.23%	17.32%	19.16%	23.91%	24.55%	24.71%	26.08%
Profit (Net Income) Margin	10.08%	11.01%	5.01%	13.86%	15.84%	18.00%	17.99%	21.20%	22.91%	36.49%	18.90%
Tax Burden Percent	80.23%	80.97%	35.65%	118.97%	97.59%	103.96%	93.90%	88.67%	93.31%	147.69%	95.70%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	75.72%
Effective Tax Rate	19.77%	19.03%	64.35%	-18.97%	2.41%	-3.96%	6.10%	12.63%	6.91%	6.59%	4.02%
Return on Invested Capital (ROIC)	9.46%	11.04%	5.32%	15.29%	15.09%	17.66%	18.10%	25.63%	29.90%	28.45%	4.01%
ROIC Less NNEP Spread (ROIC-NNEP)	8.01%	9.86%	3.93%	14.61%	9.25%	15.45%	12.97%	27.29%	28.18%	-2.29%	18.03%
Return on Net Nonoperating Assets (RNNOA)	-2.16%	-2.61%	-1.10%	-2.50%	-1.03%	-2.92%	-3.29%	-7.60%	-9.16%	0.95%	3.13%
Return on Equity (ROE)	7.30%	8.43%	4.22%	12.79%	14.06%	14.74%	14.81%	18.02%	20.75%	29.40%	7.14%
Cash Return on Invested Capital (CROIC)	-0.66%	14.95%	1.35%	-15.24%	7.16%	9.26%	17.74%	20.62%	32.47%	4.29%	-150.48%
Operating Return on Assets (OROA)	5.73%	6.41%	7.20%	6.30%	8.69%	8.84%	9.60%	12.15%	13.22%	12.94%	6.00%
Return on Assets (ROA)	4.60%	5.19%	2.57%	7.49%	8.48%	9.19%	9.01%	10.77%	12.33%	19.10%	4.35%
Return on Common Equity (ROCE)	7.30%	8.43%	4.22%	12.77%	14.04%	14.72%	14.80%	17.94%	20.60%	29.27%	7.13%
Return on Equity Simple (ROE_SIMPLE)	7.21%	8.35%	4.17%	12.43%	13.04%	13.52%	14.28%	17.74%	19.82%	24.87%	0.00%
Net Operating Profit after Tax (NOPAT)	214	257	124	429	508	645	690	1,004	1,185	1,266	878
NOPAT Margin	9.53%	10.61%	4.55%	13.73%	15.11%	17.49%	16.41%	21.74%	22.29%	20.67%	12.45%
Net Nonoperating Expense Percent (NNEP)	1.45%	1.18%	1.39%	0.68%	5.84%	2.21%	5.13%	-1.66%	1.72%	30.74%	-14.03%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	18.11%	19.21%	14.06%	2.10%
Cost of Revenue to Revenue	23.14%	22.41%	24.01%	23.58%	22.40%	21.56%	20.50%	19.46%	19.38%	20.32%	23.02%
SG&A Expenses to Revenue	7.36%	6.85%	7.22%	8.41%	6.82%	7.72%	7.68%	6.79%	7.08%	9.28%	10.91%
R&D to Revenue	34.62%	35.36%	33.35%	34.76%	33.83%	34.71%	35.79%	34.44%	34.79%	33.98%	35.15%
Operating Expenses to Revenue	64.97%	64.49%	63.24%	64.88%	62.12%	61.61%	62.02%	55.66%	56.67%	57.55%	64.01%
Earnings before Interest and Taxes (EBIT)	282	330	383	364	546	638	806	1,103	1,305	1,514	1,840
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	493	537	573	573	810	909	1,074	1,405	1,635	1,916	2,609
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.49	2.81	3.97	3.82	5.00	6.61	9.60	8.11	11.61	8.78	2.98
Price to Tangible Book Value (P/TBV)	26.06	21.88	41.29	0.00	32.26	25.20	35.28	34.76	27.87	14.76	0.00
Price to Revenue (P/Rev)	3.48	3.71	4.77	4.26	6.07	8.81	12.09	9.69	13.43	12.88	11.95
Price to Earnings (P/E)	34.50	33.64	95.19	30.76	38.32	48.85	67.08	45.43	58.05	34.86	63.28
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.90%	2.97%	1.05%	3.25%	2.61%	2.05%	1.49%	2.20%	1.72%	2.87%	1.58%
Enterprise Value to Invested Capital (EV/IC)	2.96	3.53	5.09	4.04	5.67	8.24	12.92	10.77	17.85	15.01	2.44
Enterprise Value to Revenue (EV/Rev)	3.14	3.33	4.44	4.18	5.90	8.51	11.73	9.37	13.14	12.22	13.44
Enterprise Value to EBITDA (EV/EBITDA)	14.26	15.03	21.13	22.79	24.47	34.48	45.94	30.77	42.74	39.09	36.34
Enterprise Value to EBIT (EV/EBIT)	24.98	24.47	31.58	35.91	36.33	49.13	61.25	39.18	53.52	49.47	51.54
Enterprise Value to NOPAT (EV/NOPAT)	32.90	31.38	97.66	30.46	39.03	48.63	71.50	43.08	58.94	59.14	107.98
Enterprise Value to Operating Cash Flow (EV/OCF)	14.21	13.75	19.13	30.76	24.75	31.63	33.05	24.86	41.02	53.23	62.44
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	23.16	385.67	0.00	82.25	92.74	72.94	53.55	54.29	392.40	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.07	0.06	0.04	0.13	0.03	0.03	0.02	0.00	0.00	0.00	0.48
Long-Term Debt to Equity	0.00	0.00	0.04	0.04	0.03	0.02	0.00	0.00	0.00	0.00	0.48
Financial Leverage	-0.27	-0.26	-0.28	-0.17	-0.11	-0.19	-0.25	-0.28	-0.33	-0.41	0.17
Leverage Ratio	1.59	1.63	1.64	1.71	1.66	1.60	1.64	1.67	1.68	1.54	1.64
Compound Leverage Factor	1.59	1.63	1.64	1.71	1.66	1.60	1.64	1.67	1.68	1.54	1.24
Debt to Total Capital	6.14%	6.03%	4.21%	11.87%	3.26%	2.54%	1.85%	0.37%	0.29%	0.17%	32.25%
Short-Term Debt to Total Capital	6.14%	6.03%	0.29%	8.69%	0.42%	0.54%	1.39%	0.00%	0.00%	0.00%	0.05%
Long-Term Debt to Total Capital	0.00%	0.00%	3.92%	3.17%	2.84%	2.00%	0.46%	0.37%	0.29%	0.17%	32.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.12%	0.15%	0.14%	0.10%	0.07%	0.78%	0.60%	0.36%	0.00%
Common Equity to Total Capital	93.86%	93.97%	95.67%	87.98%	96.60%	97.36%	98.08%	98.85%	99.11%	99.47%	67.75%
Debt to EBITDA	0.42	0.38	0.25	0.82	0.17	0.14	0.09	0.01	0.01	0.01	5.17
Net Debt to EBITDA	-1.54	-1.70	-1.58	-0.44	-0.73	-1.22	-1.38	-1.10	-0.96	-2.11	4.03
Long-Term Debt to EBITDA	0.00	0.00	0.23	0.22	0.15	0.11	0.02	0.01	0.01	0.01	5.16
Debt to NOPAT	0.96	0.80	1.16	1.10	0.27	0.20	0.15	0.02	0.02	0.01	15.36
Net Debt to NOPAT	-3.55	-3.55	-7.30	-0.59	-1.16	-1.72	-2.15	-1.54	-1.32	-3.19	11.98
Long-Term Debt to NOPAT	0.00	0.00	1.08	0.29	0.24	0.16	0.04	0.02	0.02	0.01	15.33
Altman Z-Score	3.53	3.82	5.00	4.17	6.78	7.69	10.39	8.69	12.22	13.85	3.17
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.06%	0.15%	0.15%	0.12%	0.09%	0.44%	0.69%	0.46%	0.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.93	1.00	1.04	0.73	0.99	1.19	1.16	1.09	1.15	2.44	1.62
Quick Ratio	0.86	0.91	0.93	0.61	0.73	0.94	0.89	0.85	0.82	1.88	1.20
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-15	348	31	-427	241	338	676	807	1,287	191	-32,984
Operating Cash Flow to CapEx	546.25%	825.78%	859.89%	423.28%	395.53%	624.40%	1,559.04%	1,250.27%	887.95%	1,142.43%	1,595.60%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-73.83
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.40
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.19
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.47	0.51	0.54	0.54	0.51	0.50	0.51	0.54	0.52	0.23
Accounts Receivable Turnover	6.29	5.88	6.12	6.21	6.07	5.52	6.23	6.77	6.44	6.84	5.78
Inventory Turnover	0.00	0.00	0.00	7.99	5.71	4.76	4.09	4.07	3.84	3.62	4.47
Fixed Asset Turnover	8.76	9.32	10.42	10.85	9.10	8.07	8.79	9.66	10.29	11.01	11.20
Accounts Payable Turnover	1.33	1.38	1.45	1.37	1.39	1.41	1.26	1.16	1.10	1.12	1.30
Days Sales Outstanding (DSO)	57.99	62.12	59.61	58.79	60.18	66.09	58.57	53.95	56.72	53.35	63.12
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	45.70	63.97	76.67	89.23	89.61	95.16	100.75	81.73
Days Payable Outstanding (DPO)	275.25	264.52	251.44	267.38	262.93	259.53	289.04	315.12	330.94	325.86	279.87
Cash Conversion Cycle (CCC)	-217.27	-202.41	-191.83	-162.89	-138.79	-116.77	-141.24	-171.55	-179.06	-171.77	-135.03
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,374	2,283	2,375	3,231	3,498	3,805	3,818	4,014	3,913	4,988	38,851
Invested Capital Turnover	0.99	1.04	1.17	1.11	1.00	1.01	1.10	1.18	1.34	1.38	0.32
Increase / (Decrease) in Invested Capital	229	-91	93	856	267	307	14	196	-102	1,076	33,862
Enterprise Value (EV)	7,034	8,064	12,099	13,055	19,816	31,353	49,334	43,233	69,864	74,895	94,819
Market Capitalization	7,794	8,976	12,999	13,303	20,401	32,456	50,811	44,734	71,394	78,898	84,296
Book Value per Share	$20.10	$21.11	$21.80	$23.41	$27.17	$32.34	$34.72	$36.07	$40.42	$58.53	$152.51
Tangible Book Value per Share	$1.92	$2.71	$2.10	($0.16)	$4.21	$8.49	$9.44	$8.42	$16.84	$34.81	($60.57)
Total Capital	3,339	3,400	3,424	3,954	4,227	5,040	5,399	5,580	6,202	9,039	41,812
Total Debt	205	205	144	469	138	128	100	21	18	16	13,485
Total Long-Term Debt	0.00	0.00	134	126	120	101	25	21	18	16	13,462
Net Debt	-760	-912	-904	-254	-591	-1,108	-1,481	-1,545	-1,568	-4,035	10,524
Capital Expenditures (CapEx)	91	71	74	100	202	159	96	139	192	123	95
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-869	-910	-970	-938	-725	-799	-1,111	-1,327	-1,140	-231	-649
Debt-free Net Working Capital (DFNWC)	95	207	78	-215	4.08	436	470	238	445	3,820	2,312
Net Working Capital (NWC)	-110	1.99	68	-559	-14	409	395	238	445	3,820	2,290
Net Nonoperating Expense (NNE)	-12	-9.84	-13	-3.95	-25	-19	-66	25	-33	-969	-455
Net Nonoperating Obligations (NNO)	-760	-912	-904	-254	-591	-1,108	-1,481	-1,545	-2,271	-4,035	10,524
Total Depreciation and Amortization (D&A)	212	207	189	209	264	271	268	301	329	402	770
Debt-free, Cash-free Net Working Capital to Revenue	-38.78%	-37.58%	-35.60%	-30.05%	-21.56%	-21.69%	-26.42%	-28.76%	-21.44%	-3.77%	-9.20%
Debt-free Net Working Capital to Revenue	4.26%	8.54%	2.88%	-6.88%	0.12%	11.84%	11.18%	5.16%	8.37%	62.34%	32.77%
Net Working Capital to Revenue	-4.89%	0.08%	2.51%	-17.90%	-0.40%	11.11%	9.39%	5.16%	8.37%	62.34%	32.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.46	$1.76	$0.91	$2.90	$3.55	$4.40	$4.96	$6.44	$8.08	$14.78	$8.13
Adjusted Weighted Average Basic Shares Outstanding	154.96M	152.02M	150.46M	149.04M	149.87M	151.14M	152.70M	153.00M	152.15M	153.14M	163.95M
Adjusted Diluted Earnings per Share	$1.43	$1.73	$0.88	$2.82	$3.45	$4.27	$4.81	$6.29	$7.92	$14.51	$8.04
Adjusted Weighted Average Diluted Shares Outstanding	158.07M	154.72M	154.87M	153.39M	154.19M	155.71M	157.34M	156.49M	155.20M	155.94M	165.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	151.45M	150.10M	148.71M	149.52M	150.53M	153.03M	153.44M	152.42M	151.99M	154.58M	191.32M
Normalized Net Operating Profit after Tax (NOPAT)	226	265	269	261	554	459	721	1,013	1,235	1,266	878
Normalized NOPAT Margin	10.07%	10.93%	9.87%	8.37%	16.48%	12.46%	17.16%	21.96%	23.22%	20.67%	12.45%
Pre Tax Income Margin	12.56%	13.60%	14.06%	11.65%	16.23%	17.32%	19.16%	23.91%	24.55%	24.71%	19.75%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.12
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.97
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.91
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.75
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.25%
Augmented Payout Ratio	123.93%	149.91%	292.91%	92.48%	61.83%	36.49%	104.19%	112.42%	98.98%	0.00%	2.25%

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	7/31/2023	10/31/2023	1/31/2024	4/30/2024	7/31/2024	10/31/2024	1/31/2025	4/30/2025	7/31/2025	10/31/2025	1/31/2026
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.55%	63.67%	10.99%	15.20%	12.65%	11.81%	-3.68%	10.28%	14.03%	37.83%	65.52%
EBITDA Growth	30.83%	77.28%	51.97%	13.49%	16.56%	-6.06%	-32.97%	34.45%	-4.22%	144.66%	94.12%
EBIT Growth	37.74%	101.98%	63.83%	15.15%	20.41%	-21.99%	-36.36%	40.71%	-16.82%	111.91%	-20.01%
NOPAT Growth	40.98%	156.61%	36.04%	7.12%	26.74%	-33.13%	-23.19%	15.18%	-45.55%	-58.02%	-35.39%
Net Income Growth	51.63%	128.62%	66.11%	7.09%	21.57%	216.20%	-33.35%	19.38%	-40.16%	-59.07%	-78.24%
EPS Growth	51.75%	128.57%	65.14%	6.82%	20.28%	218.30%	-34.60%	17.55%	-42.53%	-65.78%	-82.01%
Operating Cash Flow Growth	27.25%	-17.14%	-176.50%	-32.20%	-18.61%	72.61%	23.16%	-42.22%	47.33%	13.67%	1,370.23%
Free Cash Flow Firm Growth	237.65%	917.75%	-8,224.84%	-2,437.24%	-287.77%	-281.35%	127.54%	-197.10%	-6,725.80%	-3,994.19%	-16,637.12%
Invested Capital Growth	0.99%	-2.53%	23.94%	15.69%	21.20%	27.49%	1.09%	29.52%	675.22%	678.82%	596.30%
Revenue Q/Q Growth	7.26%	-1.10%	12.80%	-11.79%	4.88%	-1.84%	-2.83%	10.24%	8.44%	29.61%	6.83%
EBITDA Q/Q Growth	8.97%	19.70%	9.84%	-21.89%	11.91%	-3.52%	-21.63%	61.52%	-19.64%	153.91%	-39.28%
EBIT Q/Q Growth	9.77%	24.12%	13.20%	-26.57%	14.78%	-19.58%	-7.65%	68.50%	-31.54%	115.12%	-66.53%
NOPAT Q/Q Growth	14.03%	17.15%	-6.71%	-16.55%	34.92%	-38.19%	7.15%	28.88%	-36.22%	-50.17%	57.71%
Net Income Q/Q Growth	23.38%	4.04%	28.78%	-35.21%	40.06%	170.59%	-72.85%	16.04%	-29.80%	85.10%	-85.57%
EPS Q/Q Growth	23.30%	3.23%	29.02%	-34.95%	38.83%	173.18%	-73.49%	16.93%	-32.13%	62.67%	-86.07%
Operating Cash Flow Q/Q Growth	-20.40%	-41.73%	-126.92%	642.88%	-4.44%	23.58%	-111.99%	508.22%	143.66%	-4.65%	33.93%
Free Cash Flow Firm Q/Q Growth	1,916.17%	73.53%	-255.81%	47.60%	-34.41%	-67.60%	123.66%	-657.42%	-2,987.99%	0.79%	3.17%
Invested Capital Q/Q Growth	-0.34%	-6.47%	39.29%	-10.89%	4.41%	-1.62%	10.45%	14.16%	524.92%	-1.16%	-1.25%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	80.77%	82.25%	81.52%	79.35%	80.95%	78.30%	81.45%	80.16%	78.13%	70.97%	73.54%
EBITDA Margin	30.33%	36.71%	35.74%	29.41%	31.38%	30.84%	24.87%	36.44%	27.01%	52.90%	30.07%
Operating Margin	22.16%	31.72%	23.34%	22.83%	23.61%	20.28%	17.30%	23.46%	9.50%	5.38%	8.43%
EBIT Margin	24.04%	30.17%	30.28%	23.48%	25.69%	21.05%	20.00%	30.58%	19.30%	32.04%	10.04%
Profit (Net Income) Margin	24.59%	25.87%	29.53%	19.87%	26.54%	73.15%	20.44%	21.51%	13.93%	19.89%	2.69%
Tax Burden Percent	102.30%	85.75%	97.54%	84.65%	103.29%	347.56%	102.16%	87.11%	127.98%	86.82%	81.86%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	80.77%	56.37%	71.50%	32.70%
Effective Tax Rate	-2.14%	15.49%	5.01%	13.30%	-7.83%	20.97%	-2.16%	11.91%	-27.98%	13.18%	18.14%
Return on Invested Capital (ROIC)	28.61%	35.96%	24.62%	27.64%	35.73%	22.07%	19.59%	23.07%	3.53%	1.50%	2.52%
ROIC Less NNEP Spread (ROIC-NNEP)	27.01%	36.62%	15.85%	27.58%	35.00%	-5.06%	18.00%	22.62%	4.21%	12.08%	-2.53%
Return on Net Nonoperating Assets (RNNOA)	-7.71%	-11.90%	-3.25%	-8.46%	-11.44%	2.10%	-5.68%	-7.88%	1.07%	2.10%	-0.26%
Return on Equity (ROE)	20.90%	24.06%	21.37%	19.18%	24.29%	24.17%	13.91%	15.19%	4.60%	3.60%	2.26%
Cash Return on Invested Capital (CROIC)	22.59%	32.47%	4.52%	14.34%	10.88%	4.29%	20.61%	-3.61%	-149.53%	-150.48%	-146.08%
Operating Return on Assets (OROA)	13.14%	16.24%	16.45%	14.27%	15.47%	11.02%	10.29%	10.94%	4.15%	7.37%	2.67%
Return on Assets (ROA)	13.44%	13.93%	16.05%	12.08%	15.98%	38.30%	10.52%	7.70%	2.99%	4.58%	0.71%
Return on Common Equity (ROCE)	20.74%	23.90%	21.24%	19.06%	24.16%	24.06%	13.88%	15.16%	4.59%	3.60%	2.26%
Return on Equity Simple (ROE_SIMPLE)	17.17%	0.00%	20.92%	19.78%	19.28%	0.00%	22.43%	21.61%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	306	359	335	288	388	240	257	332	212	105	166
NOPAT Margin	22.63%	26.80%	22.17%	19.79%	25.46%	16.03%	17.68%	20.67%	12.16%	4.67%	6.90%
Net Nonoperating Expense Percent (NNEP)	1.60%	-0.66%	8.77%	0.06%	0.73%	27.13%	1.59%	0.45%	-0.68%	-10.57%	5.05%
Return On Investment Capital (ROIC_SIMPLE)	-	5.82%	5.01%	-	-	2.67%	2.76%	1.61%	0.50%	0.25%	0.41%
Cost of Revenue to Revenue	19.23%	17.75%	18.48%	20.65%	19.05%	21.70%	18.55%	19.84%	21.87%	29.03%	26.46%
SG&A Expenses to Revenue	7.36%	7.08%	8.69%	7.89%	9.86%	11.01%	11.48%	8.51%	16.13%	8.23%	7.59%
R&D to Revenue	35.77%	32.82%	34.78%	33.90%	33.35%	35.27%	38.01%	34.53%	35.94%	33.12%	29.68%
Operating Expenses to Revenue	58.62%	50.53%	58.19%	56.52%	57.34%	58.01%	64.14%	56.69%	68.63%	65.58%	65.11%
Earnings before Interest and Taxes (EBIT)	326	404	457	342	392	315	291	491	336	722	242
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	411	492	540	428	479	462	362	585	470	1,193	724
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	11.54	11.61	12.16	11.32	11.10	8.78	8.73	7.16	3.56	2.98	2.91
Price to Tangible Book Value (P/TBV)	39.65	27.87	37.52	23.47	21.39	14.76	14.27	11.30	0.00	0.00	0.00
Price to Revenue (P/Rev)	13.06	13.43	14.84	12.80	13.17	12.88	13.38	11.41	15.27	11.95	11.11
Price to Earnings (P/E)	66.47	58.05	57.63	56.73	57.09	34.86	38.50	32.81	49.20	63.28	80.79
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.50%	1.72%	1.74%	1.76%	1.75%	2.87%	2.60%	3.05%	2.03%	1.58%	1.24%
Enterprise Value to Invested Capital (EV/IC)	16.01	17.85	14.66	16.34	16.49	15.01	14.05	10.71	2.80	2.44	2.52
Enterprise Value to Revenue (EV/Rev)	12.73	13.14	14.61	12.55	12.87	12.22	12.75	10.83	17.10	13.44	12.09
Enterprise Value to EBITDA (EV/EBITDA)	46.75	42.74	43.91	42.33	43.04	39.09	44.55	35.67	58.93	36.34	32.71
Enterprise Value to EBIT (EV/EBIT)	60.14	53.52	53.85	51.76	52.28	49.47	57.46	45.22	77.41	51.54	54.41
Enterprise Value to NOPAT (EV/NOPAT)	68.24	58.94	62.65	60.65	60.14	59.14	65.11	54.65	103.97	107.98	119.55
Enterprise Value to Operating Cash Flow (EV/OCF)	37.82	41.02	53.24	62.25	71.44	53.23	54.25	54.93	76.32	62.44	39.64
Enterprise Value to Free Cash Flow (EV/FCFF)	71.22	54.29	358.98	122.18	166.11	392.40	68.55	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.07	0.52	0.48	0.33
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.07	0.52	0.48	0.33
Financial Leverage	-0.29	-0.33	-0.20	-0.31	-0.33	-0.41	-0.32	-0.35	0.26	0.17	0.10
Leverage Ratio	1.65	1.68	1.62	1.59	1.57	1.54	1.47	2.03	1.69	1.64	1.51
Compound Leverage Factor	1.65	1.68	1.62	1.59	1.57	1.54	1.47	1.64	0.95	1.17	0.49
Debt to Total Capital	0.30%	0.29%	0.25%	0.24%	0.20%	0.17%	0.15%	51.76%	34.18%	32.25%	24.74%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.11%	0.05%	0.05%	0.05%
Long-Term Debt to Total Capital	0.30%	0.29%	0.25%	0.24%	0.20%	0.17%	0.15%	51.65%	34.13%	32.20%	24.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.69%	0.60%	0.53%	0.50%	0.46%	0.36%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.01%	99.11%	99.22%	99.27%	99.33%	99.47%	99.85%	48.24%	65.82%	67.75%	75.26%
Debt to EBITDA	0.01	0.01	0.01	0.01	0.01	0.01	0.01	5.63	7.68	5.17	3.39
Net Debt to EBITDA	-1.27	-0.96	-0.69	-0.88	-1.02	-2.11	-2.18	-1.92	6.29	4.03	2.65
Long-Term Debt to EBITDA	0.01	0.01	0.01	0.01	0.01	0.01	0.01	5.62	7.67	5.16	3.39
Debt to NOPAT	0.02	0.02	0.01	0.01	0.01	0.01	0.01	8.63	13.55	15.36	12.40
Net Debt to NOPAT	-1.85	-1.32	-0.99	-1.26	-1.42	-3.19	-3.19	-2.94	11.10	11.98	9.68
Long-Term Debt to NOPAT	0.02	0.02	0.01	0.01	0.01	0.01	0.01	8.61	13.53	15.33	12.37
Altman Z-Score	12.12	11.93	14.34	14.56	15.03	13.55	14.94	4.70	3.36	3.09	3.73
Noncontrolling Interest Sharing Ratio	0.76%	0.69%	0.63%	0.59%	0.56%	0.46%	0.22%	0.21%	0.10%	0.09%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.20	1.15	1.29	1.86	2.02	2.44	2.68	7.02	1.62	1.62	1.36
Quick Ratio	0.92	0.82	0.88	0.99	1.10	1.88	1.99	6.34	1.16	1.20	0.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	265	461	-718	-371	-498	-835	198	-1,102	-34,024	-33,757	-32,688
Operating Cash Flow to CapEx	1,213.48%	614.07%	-217.35%	1,242.03%	1,138.27%	12,823.38%	-165.68%	495.37%	1,738.01%	1,851.84%	2,425.91%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-11.68	-232.25	0.00	-200.89
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.92	4.58	0.00	5.27
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.33	4.32	0.00	5.05
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.54	0.54	0.61	0.60	0.52	0.51	0.36	0.21	0.23	0.27
Accounts Receivable Turnover	7.80	6.44	5.21	7.83	8.82	6.84	6.21	6.77	5.86	5.78	6.32
Inventory Turnover	4.28	3.84	3.40	4.16	4.04	3.62	3.10	3.24	3.50	4.47	4.93
Fixed Asset Turnover	10.29	10.29	10.09	11.36	11.73	11.01	10.91	10.93	10.13	11.20	13.09
Accounts Payable Turnover	1.31	1.10	1.51	1.97	1.62	1.12	1.51	1.63	1.32	1.30	1.78
Days Sales Outstanding (DSO)	46.79	56.72	70.08	46.61	41.36	53.35	58.82	53.89	62.32	63.12	57.74
Days Inventory Outstanding (DIO)	85.25	95.16	107.40	87.75	90.45	100.75	117.81	112.53	104.30	81.73	74.10
Days Payable Outstanding (DPO)	278.49	330.94	242.53	185.07	224.84	325.86	241.87	224.04	277.05	279.87	205.64
Cash Conversion Cycle (CCC)	-146.45	-179.06	-65.06	-50.70	-93.02	-171.77	-65.24	-57.62	-110.43	-135.03	-73.80
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,183	3,913	5,450	4,856	5,070	4,988	5,510	6,290	39,306	38,851	38,364
Invested Capital Turnover	1.26	1.34	1.11	1.40	1.40	1.38	1.11	1.12	0.29	0.32	0.37
Increase / (Decrease) in Invested Capital	41	-102	1,053	659	887	1,076	60	1,433	34,236	33,862	32,854
Enterprise Value (EV)	66,971	69,864	79,893	79,331	83,601	74,895	77,433	67,346	110,036	94,819	96,825
Market Capitalization	68,746	71,394	81,114	80,938	85,544	78,898	81,228	70,972	98,290	84,296	88,985
Book Value per Share	$39.16	$40.42	$43.80	$46.89	$50.32	$58.53	$60.19	$64.13	$177.97	$152.51	$159.68
Tangible Book Value per Share	$11.40	$16.84	$14.20	$22.61	$26.10	$34.81	$36.81	$40.62	($79.99)	($60.57)	($45.06)
Total Capital	6,018	6,202	6,724	7,206	7,761	9,039	9,319	20,554	41,954	41,812	40,592
Total Debt	18	18	17	17	16	16	14	10,638	14,340	13,485	10,044
Total Long-Term Debt	18	18	17	17	16	16	14	10,615	14,318	13,462	10,022
Net Debt	-1,816	-1,568	-1,256	-1,643	-1,979	-4,035	-3,795	-3,626	11,746	10,524	7,841
Capital Expenditures (CapEx)	46	53	40	38	40	4.39	41	56	39	35	35
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,296	-1,140	-510	485	599	-231	156	232	-420	-649	-750
Debt-free Net Working Capital (DFNWC)	538	445	763	2,145	2,593	3,820	3,965	14,496	2,174	2,312	1,453
Net Working Capital (NWC)	538	445	763	2,145	2,593	3,820	3,965	14,473	2,151	2,290	1,431
Net Nonoperating Expense (NNE)	-27	13	-111	-1.20	-16	-856	-40	-14	-31	-343	102
Net Nonoperating Obligations (NNO)	-1,816	-2,271	-1,256	-2,332	-2,675	-4,035	-3,795	-3,626	11,692	10,524	7,816
Total Depreciation and Amortization (D&A)	85	88	83	86	87	147	71	94	134	470	483
Debt-free, Cash-free Net Working Capital to Revenue	-24.63%	-21.44%	-9.33%	7.67%	9.22%	-3.77%	2.56%	3.73%	-6.53%	-9.20%	-9.37%
Debt-free Net Working Capital to Revenue	10.23%	8.37%	13.96%	33.92%	39.93%	62.34%	65.30%	233.00%	33.78%	32.77%	18.15%
Net Working Capital to Revenue	10.23%	8.37%	13.96%	33.92%	39.93%	62.34%	65.30%	232.63%	33.43%	32.46%	17.87%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.21	$2.30	$2.95	$1.91	$2.66	$7.26	$1.91	$2.23	$1.51	$2.48	$0.34
Adjusted Weighted Average Basic Shares Outstanding	152.02M	152.15M	152.31M	152.97M	153.42M	153.14M	154.41M	154.93M	160.17M	163.95M	189.59M
Adjusted Diluted Earnings per Share	$2.17	$2.24	$2.89	$1.88	$2.61	$7.13	$1.89	$2.21	$1.50	$2.44	$0.34
Adjusted Weighted Average Diluted Shares Outstanding	154.95M	155.20M	155.33M	155.77M	156.13M	155.94M	156.19M	156.09M	161.68M	165.66M	190.76M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	304.17M	151.99M	152.54M	153.22M	153.61M	154.58M	154.62M	155.16M	185.75M	191.32M	191.56M
Normalized Net Operating Profit after Tax (NOPAT)	225	356	335	288	252	240	176	332	116	105	263
Normalized NOPAT Margin	16.64%	26.55%	22.17%	19.79%	16.53%	16.03%	12.11%	20.67%	6.65%	4.67%	10.92%
Pre Tax Income Margin	24.04%	30.17%	30.28%	23.48%	25.69%	21.05%	20.00%	24.70%	10.88%	22.91%	3.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.20	2.29	0.00	1.49
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.52	1.44	0.00	1.02
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.61	2.03	0.00	1.27
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.93	1.18	0.00	0.80
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.25%	0.00%
Augmented Payout Ratio	122.02%	98.98%	0.00%	42.41%	20.18%	0.00%	0.00%	0.00%	0.00%	2.25%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, trend-focused look at Synopsys (SNPS) using the last four years of quarterly statements. The summary highlights where the company’s cash flow, income, and balance sheet point to growth, liquidity, and risk for investors.

Strong operating cash flow across the period. Net cash from continuing operating activities has been positive in every quarter shown, including about $856.8M in Q1 2026, $670.96M in Q3 2025, and consistently solid levels in prior years (e.g., $639.7M in Q4 2025 and $562.8M in Q4 2024).
Revenue growth into 2026. Total revenue rose from about $1.50B in late 2024 to roughly $2.41B in Q1 2026, reflecting meaningful top-line expansion over the period.
Profitability in multiple quarters. Net income attributable to common shareholders was positive in several quarters, with notable figures such as approximately $448.7M in Q4 2025 and about $345.3M in Q2 2025, among others in the period.
Solid balance sheet base and equity cushion. Total Common Equity sits around $30.6B in Q1 2026, indicating a strong, liquidity-supportive capital base to fund ongoing operations and growth.
Liquidity supported by equity issuance when needed. The company raised liquidity through equity issuances, including about $90.3M in Q4 2025 and roughly $2.01B in Q1 2026, bolstering cash reserves during a growth phase.
Significant asset expansion tied to strategic activity in 2025. Total assets jumped to about $48.23B in Q3 2025 from about $23.76B in Q2 2025, signaling a material one-off balance-sheet event (primarily acquisitions and goodwill) that reflects aggressive growth activity.
Healthy cash position in early 2026. Cash & equivalents were about $2.13B in Q1 2026, helping support ongoing investments and potential buybacks or debt management.
Ongoing cash generation supports near-term investment and strategic moves. The combination of solid operating cash flow and selective equity financing provides liquidity to back growth initiatives while preserving a strong balance sheet.

One-off acquisition-driven balance-sheet expansion in 2025. In Q3 2025, Synopsys recorded a large acquisitions outflow of about $16.68B, which substantially increased total assets and goodwill, creating a large but likely non-recurring boost to asset levels.
Sharp, quarter-to-quarter asset swings due to one-time events. The jump from roughly $23.76B in total assets (Q2 2025) to about $48.23B (Q3 2025) reflects a major one-off activity (acquisitions and related balance-sheet effects) rather than a steady, ongoing trend.

Significant investing cash outflows in several quarters. Investing activities show sizeable outlays, notably the Q3 2025 acquisitions outflow of about $16.68B and other large capex increments, indicating substantial one-time and ongoing spending to fuel growth.
Large near-term negative cash impact from investing in some quarters. For example, Q3 2025 shows a substantial negative net cash from continuing investing activities (about $16.5B), contributing to a large net decrease in cash for that period.
Financing moves can dilute existing holders and increase cash outflows in some quarters. While there are positive equity raises, the mix of financing activity includes sizable cash outflows (e.g., debt repayments in some quarters and notable net cash outflows from financing activities in others), which can impact near-term liquidity and shareholder value depending on capital-structure strategy.

05/11/26 03:32 PM ETAI Generated. May Contain Errors.

Synopsys Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Synopsys' financial year ends in October. Their financial year 2025 ended on October 31, 2025.

Synopsys' net income appears to be on an upward trend, with a most recent value of $1.33 billion in 2025, rising from $225.93 million in 2015. The previous period was $2.24 billion in 2024. See Synopsys' forecast for analyst expectations on what's next for the company.

Synopsys' total operating income in 2025 was $914.93 million, based on the following breakdown:

Total Gross Profit: $5.43 billion
Total Operating Expenses: $4.52 billion

Over the last 10 years, Synopsys' total revenue changed from $2.24 billion in 2015 to $7.05 billion in 2025, a change of 214.6%.

Synopsys' total liabilities were at $19.90 billion at the end of 2025, a 391.3% increase from 2024, and a 940.8% increase since 2015.

In the past 10 years, Synopsys' cash and equivalents has ranged from $723.12 million in 2018 to $3.90 billion in 2024, and is currently $2.89 billion as of their latest financial filing in 2025.

Over the last 10 years, Synopsys' book value per share changed from 20.10 in 2015 to 152.51 in 2025, a change of 658.9%.

Related Companies

Financial statements for NASDAQ:SNPS last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synopsys (SNPS) Financials

Financials Breakdown Chart

Key Financial Trends

Synopsys Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synopsys (SNPS) Financials

Annual Income Statements for Synopsys

Quarterly Income Statements for Synopsys

Annual Cash Flow Statements for Synopsys

Quarterly Cash Flow Statements for Synopsys

Annual Balance Sheets for Synopsys

Quarterly Balance Sheets for Synopsys

Annual Metrics And Ratios for Synopsys

Quarterly Metrics And Ratios for Synopsys

Financials Breakdown Chart

Key Financial Trends

Synopsys Financials - Frequently Asked Questions

When does Synopsys' fiscal year end?

How has Synopsys' net income changed over the last 10 years?

What is Synopsys' operating income?

How has Synopsys' revenue changed over the last 10 years?

How much debt does Synopsys have?

How much cash does Synopsys have?

How has Synopsys' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools